These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases. Senchak AJ; Dann M; Cable B; Bessinger G Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466 [TBL] [Abstract][Full Text] [Related]
5. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. Welsh O; Olazarán Z; Gómez M; Salas J; Berman B J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206 [TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. Ho NT; Lansang P; Pope E J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622 [TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540 [TBL] [Abstract][Full Text] [Related]
8. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars. Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440 [TBL] [Abstract][Full Text] [Related]
9. [Clinical application of imiquimod for the treatment of infantile hemangiomas]. Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400 [TBL] [Abstract][Full Text] [Related]
10. Involution of infantile haemangiomas after imiquimod 5% cream. Barry RB; Hughes BR; Cook LJ Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022 [TBL] [Abstract][Full Text] [Related]
11. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Hu L; Huang HZ; Li X; Lin XX; Li W Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200 [TBL] [Abstract][Full Text] [Related]
12. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma. Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472 [TBL] [Abstract][Full Text] [Related]
13. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. Cohen PR; Schulze KE; Tschen JA; Hetherington GW; Nelson BR South Med J; 2006 Apr; 99(4):396-402. PubMed ID: 16634252 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of vulvar Bowen's disease with topical imiquimod 5% cream. Kim YJ; Kim JW; Koh BK Int J Dermatol; 2006 Feb; 45(2):151-3. PubMed ID: 16445508 [No Abstract] [Full Text] [Related]